The Impact of Chronic Obstructive Pulmonary Disease and Smoking on Mortality and Kidney Transplantation in End-Stage Kidney Disease.
AffiliationRegional Kidney Centre, Letterkenny General Hospital, Health Services Executive-West, Donegal, Ireland.
MetadataShow full item record
CitationThe Impact of Chronic Obstructive Pulmonary Disease and Smoking on Mortality and Kidney Transplantation in End-Stage Kidney Disease. 2012, 36 (3):287-295 Am. J. Nephrol.
JournalAmerican journal of nephrology
AbstractBackground: Chronic obstructive pulmonary disease (COPD) and tobacco use are leading causes of morbidity and mortality. The prevalence and clinical impact of COPD on mortality and kidney transplantation among patients who begin dialysis therapy is unclear. Methods: We explored the clinical impact of COPD and continued tobacco use on overall mortality and kidney transplantation in a national cohort study of US dialysis patients. National data on all dialysis patients (n = 769,984), incident between May 1995 and December 2004 and followed until October 31, 2006, were analyzed from the United States Renal Data System. Prevalence and period trends were determined while multivariable Cox regression evaluated relative hazard ratios (RR) for death and kidney transplantation. Results: The prevalence of COPD was 7.5% overall and increased from 6.7 to 8.1% from 1995-2004. COPD correlated significantly with older age, cardiovascular conditions, cancer, malnutrition, poor functional status, and tobacco use. Adjusted mortality risks were significantly higher for patients with COPD (RR = 1.20, 95% CI 1.18-1.21), especially among current smokers (RR = 1.28, 95% CI 1.25-1.32), and varied inversely with advancing age. In contrast, the adjusted risks of kidney transplantation were significantly lower for patients with COPD (RR = 0.47, 95% CI 0.41-0.54, for smokers and RR = 0.54, 95% CI 0.50-0.58, for non-smokers) than without COPD [RR = 0.72, 95% CI 0.70-0.75, for smokers and RR = 1.00 for non-smokers (referent category)]. Conclusions: Patients with COPD who begin dialysis therapy in the US experience higher mortality and lower rates of kidney transplantation, outcomes that are far worse among current smokers.
- Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada.
- Authors: Rabbat CG, Thorpe KE, Russell JD, Churchill DN
- Issue date: 2000 May
- Survival trends of US dialysis patients with heart failure: 1995 to 2005.
- Authors: Stack AG, Mohammed A, Hanley A, Mutwali A, Nguyen H
- Issue date: 2011 Aug
- Differential impact of smoking on mortality and kidney transplantation among adult Men and Women undergoing dialysis.
- Authors: Stack AG, Yermak D, Roche DG, Ferguson JP, Elsayed M, Mohammed W, Casserly LF, Walsh SR, Cronin CJ
- Issue date: 2016 Jul 26
- Thrombotic microangiopathy in United States long-term dialysis patients.
- Authors: Perkins RM, Reynolds JC, Ahuja TS, Reid T, Agodoa LY, Bohen EM, Yuan CM, Abbott KC
- Issue date: 2006 Jan
- Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States.
- Authors: Stack AG
- Issue date: 2003 Feb